You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 2, February 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Anemia in Hemodialysis Patients

Changing Concepts in Management

Michael R. Higgins, MB, ChB, FRCP(C), FRCP(Edin); Michael Grace, PhD, PEng; Raymond A. Ulan, MD, FRCP(C); Donald S. Silverberg, MD, FRCP(C); Kelvin B. Bettcher, MB, BS, FRCP(C); John B. Dossetor, MD, FACP, FRCP(C)

Arch Intern Med. 1977;137(2):172-176.


Abstract

The association between anemia and chronic renal failure has been recognized since the early 19th century. With the introduction of regular dialysis treatment, an understanding of all aspects of this uremic complication has become of great importance, including an appreciation of the hazards of multiple blood transfusions. This analysis of hemoglobin levels and transfusion requirements in 84 dialysis patients focuses specific attention on hemolytic mechanisms, blood loss, and the effect of bilateral nephrectomy on erythropoiesis.

Because no replacement for renal erythropoietin is available, particular attention must be paid to less important, but partially correctable factors that contribute to anemia. Blood transfusion requirements can then be reduced to a minimum, together with the risks of hypersplenism, hepatitis, and sensitization of the patient to alloantigens.

(Arch Intern Med 137:172-176, 1977)



Author Affiliations

From the University of Alberta, Edmonton, Alberta, Canada (Drs Higgins, Silverberg, Bettcher, and Dossetor); the W. W. Cross Cancer Institute, Edmonton, Alberta, Canada (Dr Grace); and the University Hospital, London, Ontario, Canada (Dr Ulan).


Footnotes

Accepted for publication May 18, 1976.

Reprint requests to University Hospital, Room 3205, Edmonton, Alberta T6G 2B7, Canada (Dr Higgins).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Blood transfusion use in non-dialysis-dependent chronic kidney disease patients aged 65 years and older
Ibrahim et al.
Nephrol Dial Transplant 2009;24:3138-3143.
ABSTRACT | FULL TEXT  

Erythropoietin Therapy, Hemoglobin Targets, and Quality of Life in Healthy Hemodialysis Patients: A Randomized Trial
Foley et al.
CJASN 2009;4:726-733.
ABSTRACT | FULL TEXT  

Hemoglobin Targets and Blood Transfusions in Hemodialysis Patients without Symptomatic Cardiac Disease Receiving Erythropoietin Therapy
Foley et al.
CJASN 2008;3:1669-1675.
ABSTRACT | FULL TEXT  

Medical Management of Home Hemodialysis Patients
WRIGHT and MYERS
ANN INTERN MED 1978;89:367-372.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.